Yazarlar : Giacchino M, Milano GM, Carraro F, Bezzio S, Pegoraro A, Aversa F, Cesaro S.

Yayın : Pediatr Rep.

Yayın Yılı : 2011

Pubmed Linki : http://www.ncbi.nlm.nih.gov/pubmed/21647279

Konu : Enfeksiyon

Literatür İçeriği :  

Abstract

Invasive fungal infections (IFI) are an important complication in pediatric haematological and oncological patients who undergo intensive chemotherapy for leukemia, solid tumour at advanced stage or relapsed, and hematopoietic stem cell transplantation. The incidence of IFI is lower than bacterial infection but mortality rate remains high. This review is designed to help paediatric oncologists in choosing the appropriate anti-fungal strategy and agents for prophylaxis, empirical, pre-emptive and specific therapy on the basis of published evidence.

Literatür Arşivi